M10.1
Lead-induced gout
Clinical Classification Guidelines
Code First
- toxic effects of lead and its compounds (T56.0-)
Medical Intelligence & Overview
Lead-induced gout, classified under ICD-10 code M10.1, is a type of gout caused by prolonged exposure to lead. Gout is a form of inflammatory arthritis characterized by the accumulation of uric acid crystals in the joints. In this specific form, lead acts as a toxin that impairs the body’s ability to eliminate uric acid, leading to its buildup and subsequent joint inflammation. Recognizing the link between lead exposure and gout is important for diagnosis and management, especially in people with known occupational or environmental lead exposure.
Causes & Symptoms
Clinical Causes: Chronic exposure to lead through occupational settings such as mining, construction, or manufacturing involving lead materials. Prolonged use of lead-containing products or containers. Environmental exposure from lead-contaminated water, soil, or paint in older buildings. Inherited or metabolic conditions that impair lead elimination, increasing susceptibility. Use of certain medications that contain lead as a component.
Key Symptoms: Sudden attacks of severe joint pain, often starting in the big toe. Redness and swelling in affected joints. Increased warmth around the inflamed joint. Persistent joint discomfort between attacks. Possible presence of tophi, which are uric acid crystal deposits under the skin. Signs of systemic inflammation, such as fever in some cases. Symptoms typically develop gradually and can become recurrent if lead exposure persists.
Diagnostic & Treatment
Diagnosis Path: Diagnosis of lead-induced gout involves a combination of medical history, physical examination, and laboratory tests. Doctors will inquire about potential lead exposure sources and assess joint symptoms. Blood tests measuring uric acid levels can help identify hyperuricemia. Additionally, blood lead level testing confirms lead exposure. Joint aspiration may be performed in some cases to analyze synovial fluid for uric acid crystals, which are indicative of gout. Imaging studies like ultrasound or X-rays can detect joint damage or crystals deposits.
Treatment Protocols: Management of lead-induced gout includes reducing exposure to lead and addressing gout symptoms. Treatment options involve:
Clinical Advice & FAQs
Billing Guidance
Is M10.1 a billable ICD-10 code?
Yes, M10.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M10.1?
Clinical documentation must specify the nature of Lead-induced gout and any associated comorbidities for accurate reporting.
Cite this Clinical Reference